drugset / Trial / NCT01959230

Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Participants With Ocular Redness

NCT01959230

Phase 3 Completed 60 enrolled Bausch & Lomb Incorporated ORA, Inc. · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

To compare the efficacy and safety of brimonidine tartrate ophthalmic solution 0.025% with its vehicle for the treatment of ocular redness in a population of adult and geriatric participants with ocular redness.

Timeline

Start
2013-11-07
Primary completion
2013-12-20
Completion
2013-12-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Brimonidine Small molecule 0.025 % Topical

Indications